Delayed hyperacute xenograft rejection in porcine to canine fetal liver transplantation

Transplant Immunology

Volumn 7, Issue 2, 1999, Pages 95-99

  Kanai, Nobuyuki ^a   Morita, Naokatsu ^a   Munkhbat, Batmunkh ^a   Gansuvd, Balgansuren ^a   Kise, Yoshifumi ^a   Sato, Koshi ^a   Takahashi, Tsuyoshi ^a   Kakita, Akira ^a   Nagamachi, Yukio ^a   Hagihara, Masao ^a   Tsuji, Kimiyoshi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; COMPLEMENT COMPONENT C3; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; LECTIN; OLIGOSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FETAL TISSUE TRANSPLANTATION; FETUS; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; LECTIN BINDING; LIVER CIRCULATION; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

EID: 0032822111     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80025-2     Document Type: Article

References (28)

1. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet. 341:1993;65-71.
2. Makowka L, Cramer DV, Hoffman A, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation. 59:1995;1654-1659.
3. Reemtsma K. Renal heterotransplantation from nonhuman primates to man. Ann NY Acad Sci. 162:1969;412-418.
4. Perper RJ, Najarian JS. Experimental renal heterotransplantation. I. In widely divergent species. Transplantation. 4:1966;377-388.
5. Galili U, Rachmilewitz EA, Peleg A, Flechner A. Unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med. 160:1984;1519-1531.
6. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG. II. The specific recognition of a (1-3) linked galactose residues. J Exp Med. 162:1985;573-582.
7. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. Man, apes and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem. 263:1988;17755-17762.
8. Kux M, Boehming HJ, Amemiya H, et al. Modification of hyperscute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial of citrate. Surgery. 70:1971;103-112.
9. Makowka L, Miller C, Chapchap P, et al. Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg. 206:1987;482-495.
10. Veyron P, Mutin M, Touraine JL. Transplantation of fetal liver cells corrects accumulation of lipids in tissues and prevents fatal neuropathy in cholesterol-storage disease BALB/c mice. Transplantation. 62:1996;1039-1045.
11. Hagihara M, Shimura T, Takebe K, et al. Effect of iso and xeno fetal liver fragments transplantation on acute and chronic liver failure in rats. Cell Transplantation. 3:1994;283-290.
12. Mieles L, Ye Y, Luo Y, et al. Auxiliary liver allografting and xenografting in the nonhuman primate. Transplantation. 59:1995;1670-1676.
13. Tsuji K, Kanai N, Kise Y, et al. Can fetal xeno whole-organ (heart, lung, kidney, and liver) grafts escape from hyperacute rejection in experimental discordant combination compared with adult xenografts? Transplant Proc. 29:1997;3022-3023.
14. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nature Med. 9:1995;869-873.
15. Henry ML, Han LK, Davies EA, et al. Antibody depletion prolongs xenograft survival. Surgery. 115:1994;355-361.
16. Abouna GM, Al-Abdullah IH, H Llia, Kelly-Sullivan D. Comparison of the effect of plasmapheresis using human albumin or dextran 40 on the survival of pig-to-dog renal xenografts. Transplant Proc. 28:1996;212-214.
17. Lie TS, Fasske E, Bassewitz, et al. The effect of high dosage prednisolon on the hyperacute rejection of the orthotopic dog-to-pig liver xenograft. Res Exp Med. 157:1972;107-122.
18. Hengster P, Linke R, Feichtinger J, et al. Mechanism of hyperacute rejection of discordant liver xenograft. Xenotransplantation. 3:1996;246-251.
19. Schraa EO, Sshotman SN, Scheringa M, Daha MR, Marquet RL, Ijzermans NM. Discordant liver transplantation in the guinea pig to rat model does not lead to classical hyperacute rejection. Xenotransplantation. 3:1996;321-327.
20. Pruitt SK, Baldwin WM III, Marsh HC Jr, Lin SS, Yeh CG, Bolliger RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation. 52:1991;868-873.
21. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1:1995;964-966.
22. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation. 63:1997;149-155.
23. Hancock WW, Bach FH. The immunopathology of discordant xenograft reaction. Xeno. 2:1994;68-74.
24. Kelso A, Clouston A. Cytokines in transplantation. 1996;Springer, London.
25. Alvarado CG, Cotterell AH, McCurry KR, et al. Variation in the level of xenoantigen expression in porcine organs. Transplantation. 59:1995;1589-1596.
26. Vaughan HA, McKenzie IFC, Sandrin MS. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose α (1-3) galactose reactive lectin. Transplantation. 59:1995;102-109.
27. Collins BH, Parker W, Platt JL. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation. 1:1994;36-46.
28. Hagihara M, Shimura T, Takebe K, Watanabe K, Munkhbat B, Tsuji K. Immunohistochemical study of isogenic fetal liver fragment transplants in rats. Transplant Proc. 26:1994;3499.